| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:12:22 UTC |
|---|
| Update date | 2020-09-17 15:40:58 UTC |
|---|
| Primary ID | FDB016335 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Isoliquiritigenin |
|---|
| Description | Isoliquiritigenin, also known as 6'-deoxychalcone or GU 17, belongs to the class of organic compounds known as 2'-hydroxychalcones. These are organic compounds containing chalcone skeleton that carries a hydroxyl group at the 2'-position. Thus, isoliquiritigenin is considered to be a flavonoid lipid molecule. Isoliquiritigenin is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Isoliquiritigenin is a bitter tasting compound. Outside of the human body, Isoliquiritigenin has been detected, but not quantified in, several different foods, such as java plums, tea leaf willows, sweet marjorams, common grapes, and black mulberries. This could make isoliquiritigenin a potential biomarker for the consumption of these foods. Isoliquiritigenin is a phenolic chemical compound found in licorice. |
|---|
| CAS Number | 961-29-5 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| (e)-1-(2,4-Dihydroxy-phenyl)-3-(4-hydroxy-phenyl)-propenone | ChEBI | | (e)-1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propene-1-one | ChEBI | | 2',4,4'-Trihydroxychalcone | ChEBI | | 4,2',4'-Trihydroxychalcone | ChEBI | | trans-2',4,4'-Trihydroxychalcone | ChEBI | | 1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one | HMDB | | 1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one | HMDB | | 2',4',4-Trihydroxychalcone | HMDB, MeSH | | 2',4'-Dihydroxy-3-(P-hydroxyphenyl)-acrylophenone | HMDB | | 2',4,4'-Trihydroxy-chalcone | HMDB | | 42'4'-Trihydroxychalcone | HMDB | | 6'-Deoxychalcone | HMDB, MeSH | | GU 17 | MeSH, HMDB | | GU-17 | MeSH, HMDB | | 2',4',4-trihydroxychalcone | biospider | | 42'4'-trihydroxychalcone | biospider | | 6'-deoxychalcone | biospider | | Acrylophenone, 2',4'-dihydroxy-3-(p-hydroxyphenyl)- | biospider | | Chalcone, 2',4,4'-trihydroxy- | biospider | | Isoliquiritigenin | db_source |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C15H12O4 |
|---|
| IUPAC name | (2E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one |
|---|
| InChI Identifier | InChI=1S/C15H12O4/c16-11-4-1-10(2-5-11)3-8-14(18)13-7-6-12(17)9-15(13)19/h1-9,16-17,19H/b8-3+ |
|---|
| InChI Key | DXDRHHKMWQZJHT-FPYGCLRLSA-N |
|---|
| Isomeric SMILES | OC1=CC=C(\C=C\C(=O)C2=C(O)C=C(O)C=C2)C=C1 |
|---|
| Average Molecular Weight | 256.2534 |
|---|
| Monoisotopic Molecular Weight | 256.073558872 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as 2'-hydroxychalcones. These are organic compounds containing chalcone skeleton that carries a hydroxyl group at the 2'-position. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Linear 1,3-diarylpropanoids |
|---|
| Sub Class | Chalcones and dihydrochalcones |
|---|
| Direct Parent | 2'-Hydroxychalcones |
|---|
| Alternative Parents | |
|---|
| Substituents | - 2'-hydroxychalcone
- Cinnamylphenol
- Hydroxycinnamic acid or derivatives
- Benzoyl
- Resorcinol
- Styrene
- Aryl ketone
- Phenol
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Monocyclic benzene moiety
- Benzenoid
- Vinylogous acid
- Acryloyl-group
- Enone
- Alpha,beta-unsaturated ketone
- Ketone
- Hydrocarbon derivative
- Organooxygen compound
- Organic oxide
- Organic oxygen compound
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Disposition | Route of exposure: Biological location: Source: |
|---|
| Role | Industrial application: Biological role: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Not Available | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 70.31%; H 4.72%; O 24.97% | DFC |
|---|
| Melting Point | Mp 200-204° (198-200°) | DFC |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | Not Available | |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | [base] lmax 428 () (MeOH-NaOH) (Berdy) | DFC |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| Predicted GC-MS | Isoliquiritigenin, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-000i-1970000000-6164f65f5d6241a006f8 | Spectrum | | Predicted GC-MS | Isoliquiritigenin, 3 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-0a4i-1034900000-76ae3aa74bffdff7ee01 | Spectrum | | Predicted GC-MS | Isoliquiritigenin, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Isoliquiritigenin, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - ESI-TOF 20V, Negative | splash10-0a4i-0000009000-afd1640b539ec58a4616 | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 10V, Negative | splash10-0a4i-0000009000-afd1640b539ec58a4616 | 2017-08-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 20V, Negative | splash10-014r-0900000000-e7c4095e90f57884e80c | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - ESI-TOF 10V, Negative | splash10-0a4i-0090000000-788e4464b6a542aa7c22 | 2017-09-12 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-qTOF , Positive | splash10-000i-0910000000-15db3efa5c81e3e8fc3e | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-TOF , negative | splash10-014r-0900000000-e7c4095e90f57884e80c | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - , positive | splash10-000i-0910000000-15db3efa5c81e3e8fc3e | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - , positive | splash10-000i-1930000000-6d143294fc9a6a343052 | 2017-09-14 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QFT 17V, positive | splash10-000j-0490000000-5d95d877601bf1780cf7 | 2020-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-IT 17V, positive | splash10-000j-0970000000-6f6553743b88b6c220e2 | 2020-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 10V, Positive | splash10-0a4i-0090000000-6646b871effe2fc1dec4 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 10V, Positive | splash10-0a4i-0790000000-a0a66b537f815a68529a | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 30V, Positive | splash10-000i-1900000000-f6d8867bba0f74e95f4c | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 50V, Positive | splash10-001c-7900000000-d9f65201f86e97a92305 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 50V, Positive | splash10-000x-9600000000-4607845a4f3c870a8b7d | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 30V, Positive | splash10-000i-1900000000-5b283194f8e6438d1cb4 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 20V, Positive | splash10-014r-0900000000-e7c4095e90f57884e80c | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 6V, Positive | splash10-0a4r-0690000000-7996084c7a5f23179366 | 2021-09-20 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - 10V, Positive | splash10-0a4i-0090000000-803b7c0679a83bac81f6 | 2021-09-20 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0a4i-0290000000-810f1a7ccbea17d944d3 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-052s-0960000000-9529b79414d923c90873 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-00ks-4910000000-f074bc6f0bf8212cf9cc | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0a4i-0290000000-a373dc716189e73d742c | 2016-08-04 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0a4i-0690000000-12c68dfca23fb3e6405d | 2016-08-04 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-066u-5910000000-ecfe8b4bdcef6eaa160e | 2016-08-04 | View Spectrum |
|
|---|
| NMR | Not Available |
|---|
| External Links |
|---|
| ChemSpider ID | 553829 |
|---|
| ChEMBL ID | CHEMBL129795 |
|---|
| KEGG Compound ID | C08650 |
|---|
| Pubchem Compound ID | 638278 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | Not Available |
|---|
| Phenol-Explorer ID | 918 |
|---|
| DrugBank ID | DB03285 |
|---|
| HMDB ID | HMDB37316 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | KQQ39-F:KQQ39-F |
|---|
| EAFUS ID | Not Available |
|---|
| Dr. Duke ID | ISOLIQUIRITIGENIN |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | C00006925 |
|---|
| HET ID | HCC |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Not Available |
|---|
| Phenol-Explorer Metabolite ID | 918 |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Aldose reductase inhibitor | 48550 | An agent that blocks the activity of aldose reductase, an enzyme involved in glucose metabolism. It reduces oxidative stress and inflammation, commonly used in managing diabetic complications, such as neuropathy, nephropathy, and retinopathy. | DUKE | | Anti-aggregant | | An agent that prevents platelet aggregation, reducing blood clot formation. Its biological role is to inhibit platelet activation, and its therapeutic applications include preventing thrombosis and stroke. Key medical uses include treating cardiovascular diseases, such as myocardial infarction and atrial fibrillation, and managing conditions that increase the risk of blood clots. | DUKE | | Anti-allergic | 50857 | An agent that reduces or blocks allergic reactions, commonly used to manage symptoms of allergies, such as itching, sneezing, and inflammation, by inhibiting the release of histamine and other chemical mediators, providing relief in conditions like hay fever, asthma, and skin allergies. | DUKE | | Anti depressant | 52217 | An agent that regulates mood, reducing symptoms of depression and anxiety by altering neurotransmitter levels in the brain, commonly used in managing depression, anxiety disorders, and other mood disorders. | DUKE | | Anti-diabetic | 52217 | An agent that regulates blood sugar levels, enhancing insulin sensitivity or secretion. Therapeutically, it's used to manage diabetes, reducing symptoms and complications, and commonly prescribed to treat type 1 and 2 diabetes, as well as gestational diabetes. | DUKE | | Anti-ischemic | 52217 | An agent that reduces or prevents tissue damage from inadequate blood flow, commonly used to manage angina, heart attacks, and strokes by improving oxygen delivery and reducing cardiac workload. | DUKE | | Anti-oxidant | 22586 | An agent that neutralizes free radicals, reducing oxidative stress and cell damage. Its biological role involves protecting cells from harm, and it has therapeutic applications in managing chronic diseases, such as cancer, diabetes, and neurodegenerative disorders, with key medical uses including anti-aging, anti-inflammatory, and cardio protective effects. | DUKE | | Anti platelet aggregation factor | 50427 | An agent that prevents platelets from clumping, reducing blood clot formation. It plays a biological role in maintaining vascular health, and has therapeutic applications in preventing thrombosis, stroke, and heart attack, with key medical uses in cardiovascular disease management and surgery. | DUKE | | Anti-spasmodic | 52217 | An agent that relaxes smooth muscle, reducing muscle spasms and cramps. It plays a biological role in regulating muscle tone and is therapeutically applied to treat conditions such as irritable bowel syndrome, menstrual cramps, and muscle spasms, providing relief from abdominal pain and discomfort. | DUKE | | Antitumor | 35610 | An agent that inhibits tumor growth and proliferation, playing a crucial role in cancer treatment. Therapeutically, antitumors are used to manage various types of cancer, including chemotherapy, targeted therapy, and immunotherapy, helping to reduce tumor size, prevent metastasis, and improve patient outcomes. | DUKE | | Anti ulcer | 49201 | An agent that reduces stomach acid and protects the mucous lining, preventing ulcer formation. It is used to treat conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, promoting healing and relieving symptoms. | DUKE | | Anti-viral | 22587 | An agent that inhibits the replication of viruses, playing a crucial role in preventing and treating viral infections. Therapeutically, anti-virals are used to manage diseases such as HIV, herpes, and influenza, reducing symptoms and slowing disease progression. Key medical uses include treating viral hepatitis, respiratory syncytial virus, and COVID-19. | DUKE | | Apoptotic | | An agent that stimulates programmed cell death, playing a crucial biological role in eliminating damaged or unwanted cells. It has therapeutic applications in cancer treatment, and key medical uses include inducing cell death in malignant cells, reducing tumor growth, and enhancing chemotherapy efficacy. | DUKE | | Cancer preventive | 35610 | An agent that inhibits the development and progression of cancer, reducing tumor formation and growth. It plays a biological role in blocking carcinogenic pathways, and has therapeutic applications in chemoprevention. Key medical uses include reducing the risk of cancer in high-risk individuals and preventing cancer recurrence. | DUKE | | Cyclooxygenase inhibitor | 35544 | An agent that blocks the activity of cyclooxygenase enzymes, reducing inflammation and pain. Therapeutically, it is used to treat conditions such as arthritis, headaches, and menstrual cramps, by decreasing prostaglandin production, a key mediator of inflammation. | DUKE | | Estrogenic | | An agent that mimics the effects of estrogen, regulating female reproductive processes and development. Therapeutically, estrogenic agents are used in hormone replacement therapy, contraception, and treating menopausal symptoms, as well as certain cases of osteoporosis and infertility. | DUKE | | Lipoxygenase inhibitor | 35856 | An agent that blocks the activity of lipoxygenase enzymes, reducing inflammation and oxidative stress. Therapeutically, it's used to manage conditions like asthma, atherosclerosis, and cancer, by inhibiting the production of pro-inflammatory leukotrienes. Key medical uses include treating respiratory and cardiovascular diseases. | DUKE | | Monoamine-oxidase inhibitor | 23924 | An agent that blocks monoamine oxidase enzymes, increasing neurotransmitter levels. Therapeutically, it reduces depression symptoms and is commonly used in managing depression, anxiety disorders, and Parkinson's disease. | DUKE | | Myorelaxant | | An agent that reduces muscle contractility by blocking nerve impulses or decreasing motor end plate excitability, used therapeutically to relieve muscle spasms, tension, and pain, commonly in managing musculoskeletal disorders, anxiety, and insomnia. | DUKE | | Peroxidase inhibitor | 23924 | An agent that blocks the activity of peroxidase enzymes, reducing oxidative stress and inflammation. Therapeutically, it has applications in managing conditions like cancer, neurodegenerative diseases, and cardiovascular disorders, where oxidative damage plays a key role. | DUKE | | Pigment | 26130 | A biological coloring agent, playing a role in skin and eye protection. Therapeutically, pigments are used in photodynamic therapy and skin camouflage. Medically, they are used to treat conditions like vitiligo, albinism, and skin discoloration, as well as in diagnostic imaging and wound healing applications. | DUKE | | Quinone-reductase inhibitor | 23924 | An agent that blocks the activity of quinone reductase, an enzyme involved in cellular detoxification and antioxidant processes. It has therapeutic applications in cancer treatment, neuroprotection, and inflammation reduction, with key medical uses including chemotherapy potentiation and neurodegenerative disease management. | DUKE | | Tyrosine-kinase inhibitor | 23924 | An agent that blocks tyrosine kinase enzymes, reducing cell signaling and proliferation. Therapeutically, it's used to treat cancers, such as leukemia and breast cancer, by inhibiting tumor growth, and also has applications in managing certain autoimmune and inflammatory diseases. | DUKE | | Vasorelaxant | | An agent that promotes vasorelaxation, reducing vascular tension and blood pressure. It plays a biological role in regulating blood flow and is therapeutically used to treat hypertension, angina, and heart failure, improving cardiovascular health. | DUKE |
|
|---|
| Enzymes | Not Available |
|---|
| Pathways | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | | Flavor | Citations |
|---|
| bitter |
- Ayana Wiener, Marina Shudler, Anat Levit, Masha Y. Niv. BitterDB: a database of bitter compounds. Nucleic Acids Res 2012, 40(Database issue):D413-419. DOI:10.1093/nar/gkr755
|
|
|---|
| Files |
|---|
| MSDS | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004). — Shinbo, Y., et al. 'KNApSAcK: a comprehensive species-metabolite relationship database.' Plant Metabolomics. Springer Berlin Heidelberg, 2006. 165-181.
|
|---|